Abstract
References
Articles referenced by this article (19)
Title not supplied
Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., e1410- 2017
Activating platinum anticancer complexes with visible light.
Angew Chem Int Ed Engl, (4):804-805 2010
MED: 21246674
Cisplatin: a review of toxicities and therapeutic applications.
Vet Comp Oncol, (1):1-18 2008
MED: 19178659
Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials.
Lung Cancer, (1):1-11 2007
MED: 17720276
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo.
Proc Natl Acad Sci U S A, (5):1850-1855 2011
MED: 21233423
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.
Chem Rev, (5):3436-3486 2016
MED: 26865551
Targeting tumors with nanobodies for cancer imaging and therapy.
J Control Release, (3):607-617 2013
MED: 24035975
Ablynx's nanobody fragments go places antibodies cannot.
Nat Biotechnol, (12):1115-1117 2017
MED: 29220018
Show 9 more references (10 of 19)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/135546562
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1039/c9cc01391a
Article citations
Single-Domain Antibodies as Antibody-Drug Conjugates: From Promise to Practice-A Systematic Review.
Cancers (Basel), 16(15):2681, 27 Jul 2024
Cited by: 0 articles | PMID: 39123409 | PMCID: PMC11311928
Review Free full text in Europe PMC
What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review.
Int J Nanomedicine, 19:9503-9547, 14 Sep 2024
Cited by: 0 articles | PMID: 39296940 | PMCID: PMC11410046
Review Free full text in Europe PMC
Unlocking the potential of bispecific ADCs for targeted cancer therapy.
Front Med, 18(4):597-621, 23 Jul 2024
Cited by: 0 articles | PMID: 39039315
Review
Reforming solid tumor treatment: the emerging potential of smaller format antibody-drug conjugate.
Antib Ther, 7(2):114-122, 16 Feb 2024
Cited by: 2 articles | PMID: 38566971 | PMCID: PMC10983081
Review Free full text in Europe PMC
Single-domain antibodies as therapeutics for solid tumor treatment.
Acta Pharm Sin B, 14(7):2854-2868, 15 Mar 2024
Cited by: 2 articles | PMID: 39027249 | PMCID: PMC11252471
Review Free full text in Europe PMC
Go to all (16) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Conjugation of oxaliplatin with PEGylated-nanobody for enhancing tumor targeting and prolonging circulation.
J Inorg Biochem, 223:111553, 24 Jul 2021
Cited by: 8 articles | PMID: 34340059
Reprogramming axial ligands facilitates the self-assembly of a platinum(iv) prodrug: overcoming drug resistance and safer in vivo delivery of cisplatin.
Chem Commun (Camb), 54(66):9167-9170, 01 Aug 2018
Cited by: 8 articles | PMID: 30062328
Clustered nanobody-drug conjugates for targeted cancer therapy.
Chem Commun (Camb), 56(65):9344-9347, 01 Aug 2020
Cited by: 5 articles | PMID: 32672289
Anticancer platinum (IV) prodrugs with novel modes of activity.
Curr Top Med Chem, 11(21):2602-2612, 01 Jan 2011
Cited by: 37 articles | PMID: 22039869
Review
Funding
Funders who supported this work.
National Natural Science Foundation of China (2)
Grant ID: 21573213
Grant ID: 21877103